View printer-friendly version
« Back
March 12, 2012 1:26 p.m.
Teva to Present at the Barclays Capital Global Healthcare Conference

JERUSALEM--(BUSINESS WIRE)--Mar. 12, 2012-- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the Barclays Capital Global Healthcare Conference in Miami. William Marth, President & CEO, Teva Pharmaceuticals - Americas, will present on Tuesday, March 13, 2012.

 

What:

Teva Presentation at the Barclays Capital Global Healthcare Conference
 

Who:

William Marth, President & CEO, Teva Pharmaceuticals - Americas
 

When:

Tuesday, March 13, 2012 at 4:15 P.M. (ET)
 

Where:

http://ir.tevapharm.com/phoenix.zhtml?c=73925&p=irol-presentations or

http://cc.talkpoint.com/barc002/031312a_lp/?entity=14_6HUP8KR

 

How:

Live over the Internet – log on to the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva’s website.

 

About Teva

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $18.3 billion in net revenues in 2011.

Source: Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.
IR:
Kevin C. Mannix, 215-591-8912 (United States)
Tomer Amitai, 972 (3) 926-7656 (Israel)
or
PR:
Denise Bradley, 215-591-8974 (United States)
Shir Altay-Hagoel, 972 (3) 926-7590 (Israel)